dichloroacetic acid has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filimonov, AS; Filimonova, MV; Makarchuk, VM; Podosinnikova, TS; Samsonova, AS; Shevchenko, LI | 1 |
| Boychuk, IV; Dasyukevich, OI; Fedorchuk, AG; Kolesnik, DL; Pyaskovskaya, ON; Solyanik, GI | 1 |
2 other study(ies) available for dichloroacetic acid and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Comparison of Antitumor Effects of Combined and Separate Treatment with NO Synthase Inhibitor T1023 and PDK1 Inhibitor Dichloroacetate.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Dichloroacetic Acid; Female; Mice; Nitric Oxide Synthase; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Thiourea | 2019 |
Aconitine-containing agent enhances antitumor activity of dichloroacetate against Ehrlich carcinoma.
Topics: Aconitine; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Dichloroacetic Acid; Disease Models, Animal; Drug Synergism; Humans; Lactate Dehydrogenases; Lactic Acid; Mice; Nitric Oxide; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |